Study of the effect of different drug treatment strategies in patients with hypertension
Analysis of effectiveness of fixed, free and not traditional combinations of antihypertensive medications in the treatment of patients with arterial hypertension. Use of extended-release form of metoprolol in patients with mild and moderate hypertension.
| Рубрика | Медицина |
| Вид | статья |
| Язык | английский |
| Дата добавления | 02.10.2024 |
| Размер файла | 717,3 K |
Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже
Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.
24. Lash, J. P., Wang, X., Greene, T., Gadegbeku, C. A., Hall, Y., Jones, K., Kusek, J. W., Sika, M., Unruh, M., & African American Study of Kidney Disease and Hypertension Trial Study Group (2006). Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management. American journal of kidney diseases: the official journal of the National Kidney Foundation, 47(6), 956-964. https://doi.org/10.1053/j.ajkd.2006.02.175
25. Lins, R., Aerts, A., Coen, N., Hermans, C., MacDonald, K., Brieм, H., Lee, C., Shen, Y. M., Vancayzeele, S., Mecum, N., & Abraham, I. (2011). Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study). The Annals of pharmacotherapy, 45(6), 727-739. https://doi.org/10.1345/aph.1P663
26. Luomanma?ki, K., Inkovaara, J., Hartikainen, M., Helin, M., Viikari, J., Kataja, M., Ekman, K., & Harjula, K. (1992). Efficacy and tolerability of isradipine and metoprolol in treatment of hypertension: the Finnish Isradipine Study in Hypertension (FISH). Journal of cardiovascular pharmacology, 20(2), 296-303. https://doi.org/10.1097/00005344-199208000-00016
27. Mallat, S. G., Itani, H. S., & Tanios, B. Y. (2013). Current perspectives on combination therapy in the management of hypertension. Integrated blood pressure control, 6, 69-78. https://doi.org/10.2147/IBPC.S33985
28. Mancia, G., Fagard, R., Narkiewicz, K., Redуn, J., Zanchetti, A., Bцhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D. E., Jaarsma, T., Kirchhof, P., Kjeldsen, S. E., Laurent, S., Manolis, A. J., Nilsson, P. M., Ruilope, L. M., Schmieder, R. E., … Task Force Members (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of hypertension, 31(7), 1281-1357. https:// doi.org/10.1097/01.hjh.0000431740.32696.cc
29. Marre, M., Lievre, M., Chatellier, G., Mann, J. F., Passa, P., Meмnard, J., & DIABHYCAR Study Investigators (2004). Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ (Clinical research ed.), 328(7438), 495. https://doi.org/10.1136/bmj.37970.629537.0D
30. Matsui, Y., Eguchi, K., O'Rourke, M. F., Ishikawa, J., Miyashita, H., Shimada, K., & Kario, K. (2009). Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension (Dallas, Tex.: 1979), 54(4), 716-723. https://doi.org/10.1161/ HYPERTENSIONAHA.109.131466
31. Mayer-Hamblett, N., Ratjen, F., Russell, R., Donaldson, S. H., Riekert, K. A., Sawicki, G. S., Odem-Davis, K., Young, J. K., Rosenbluth, D., Taylor-Cousar, J. L., Goss, C. H., Retsch-Bogart, G., Clancy, J. P., Genatossio, A., O'Sullivan, B. P., Berlinski, A., Millard, S. L., Omlor, G., Wyatt, C. A., Moffett, K., … SIMPLIFY Study Group (2023). Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. The Lancet. Respiratory medicine, 11(4), 329-340. https://doi.org/10.1016/S2213-2600(22)00434-9
32. Ogihara, T., Saruta, T., Rakugi, H., Matsuoka, H., Shimamoto, K., Shimada, K., Imai, Y., Kikuchi, K., Ito, S., Eto, T., Kimura, G., Imaizumi, T., Takishita, S., Ueshima, H., & Valsartan in Elderly Isolated Systolic Hypertension Study Group (2010). Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension (Dallas, Tex.: 1979), 56(2), 196-202. https://doi.org/10.1161/HYPERTENSIONAHA.109.146035
33. Oparil, S., Giles, T., Ofili, E. O., Pitt, B., Seifu, Y., Hilkert, R., Samuel, R., & Sowers, J. R. (2011). Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy. Journal of hypertension, 29(1), 161-170. https://doi.org/10.1097/HJH.0b013e32834000a7
34. Philipp, T., Smith, T. R., Glazer, R., Wernsing, M., Yen, J., Jin, J., Schneider, H., & Pospiech, R. (2007). Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clinical therapeutics, 29(4), 563-580. https://doi.org/10.1016/j.clinthera.2007.03.018
35. Pogue, V., Rahman, M., Lipkowitz, M., Toto, R., Miller, E., Faulkner, M., Rostand, S., Hiremath, L., Sika, M., Kendrick, C., Hu, B., Greene, T., Appel, L., Phillips, R. A., & African American Study of Kidney Disease and Hypertension Collaborative Research Group (2009). Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (Dallas, Tex.: 1979), 53(1), 20-27. https://doi.org/10.1161/ HYPERTENSIONAHA.108.115154
36. Rekovets O., Sirenko Yu., Torbas O., Kushnir S., Primak G. The use of fixed double and triple combinations in achieving the target level of blood pressure during daily monitoring in patients with arterial hypertension. Bukovynskyi Medychnyi Visnyk. 2020, № 2 (94), с. 102-112. https://doi.org/10.24061/2413-0737. XXIV.2.94.2020.50
37. Sawada, T., Yamada, H., Dahlцf, B., Matsubara, H., & KYOTO HEART Study Group (2009). Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. European heart journal, 30(20), 2461-2469. https://doi.org/10.1093/eurheartj/ehp363 (Retraction published Eur Heart J. 2013 Apr;34(14):1023)
38. Schrader, J., Lьders, S., Kulschewski, A., Hammersen, F., Zьchner, C., Venneklaas, U., Schrandt, G., Schnieders, M., Rangoonwala, B., Berger, J., Dominiak, P., Zidek, W., & MARPLE Study Group (2006). Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. Journal of hypertension, 24(3), 541-548. https://doi.org/10.1097/01. hjh.0000209991.48928.c4
39. Sirenko Yu., Rekovets O., Andriyevskaya S., Babak O., Govorova O., Rudyk Yu. Antihypertensive efficacy of ramipril in patients with mild and moderate arterial hypertension (results of the multicenter study RASH - Ramipril Study in patient with arterial Hypertension). Ukrayinsky cardiologichnyi journal. 2007. №1. С. 41-47
40. Sirenko Yu., Rekovets O., Dobrokhod A. Evaluation of the effect of monoand combined antihypertensive therapy with dihydropyridine and non-dihydropyridine calcium antagonists on office blood pressure and blood pressure during daily monitoring in patients with mild and moderate arterial hypertension "Arterialna hypertensia" 1 (45) 2016, С. 45 - 66.
41. Sirenko Yu., Rekovets O. The influence of metoprolol-retard on the morning rise in blood pressure in patients with mild and moderate arterial hypertension according to 24-hour blood pressure monitoring. Ukrayinsky cardiologichnyi journal. 2006. № 3. С. 73-77
42. Sison, J., Assaad-Khalil, S. H., Najem, R., Kitchlew, A. R., Cho, B., Ueng, K. C., Shete, A., & Knap, D. (2014). Realworld clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study. Current medical research and opinion, 30(10), 1937-1945. https://doi.org/10.1185/03007995.2014.942415
43. Sison, J., Vega, R. M. R., Dayi, H., Bader, G., & Brunel, P. (2018). Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies. Current medical research and opinion, 34(3), 501-515. https://doi.org/10.1080/03007995.2017.1412682
44. Sleight P. (2000). The HOPE Study (Heart Outcomes Prevention Evaluation). Journal of the renin-angiotensin-aldosterone system: JRAAS, 1(1), 18-20. https://doi.org/10.3317/jraas.2000.002
45. Waeber, B., & Ruilope, L. M. (2009). Amlodipine and valsartan as components of a rational and effective fixed-dose combination. Vascular health and risk management, 5(1), 165-174. https://doi.org/10.2147/vhrm.s3134
46. Weycker, D., Keskinaslan, A., Levy, D. G., Edelsberg, J., Kartashov, A., & Oster, G. (2008). Effectiveness of addon therapy with amlodipine in hypertensive patients receiving valsartan. Blood pressure. Supplement, 2, 5-12. https://doi. org/10.1080/08038020802316536
47. White W. Blood pressure monitoring in cardiovascular medicine and therapeutics. New Jersey: Humana Press, 2001. 308 p.
Размещено на Allbest.ru
...Подобные документы
Causes of ischemic stroke. Assessment of individual risk for cardiovascular disease in humans. The development in patients of hypertension and coronary heart disease. Treatment in a modern hospital disorders biomarkers of coagulation and fibrinolysis.
статья [14,8 K], добавлен 18.04.2015The pathological process Acute Respiratory Distress Syndrome (ARDS). Specific challenges in mechanical ventilation of patients with ARDS. Causes of ARDS, and differential diagnosis. Treatment strategies and evidence behind them. Most common causes ARDS.
презентация [2,6 M], добавлен 21.05.2015Concept and characteristics of focal pneumonia, her clinical picture and background. The approaches to the diagnosis and treatment of this disease, used drugs and techniques. Recent advances in the study of focal pneumonia. The forecast for recovery.
презентация [1,5 M], добавлен 10.11.2015Body Water Compartments. The main general physico-chemical laws. Disorders of water and electrolyte balance. Methods bodies of water in the body, and clinical manifestations. Planning and implementation of treatment fluid and electrolyte disorders.
презентация [1,1 M], добавлен 11.09.2014Addiction as a brain disease. Why Some are Addicted and others not. Symptoms of drug addiction. Local treatment facilities. Tips for recovery. Interesting statistics. Mental disorders, depression or anxiety. Method of drug use: smoking or injecting.
презентация [4,7 M], добавлен 26.03.2016The major pathogens and symptoms of cholera - an acute intestinal anthroponotic infection caused by bacteria of the species Vibrio cholerae. Methods of diagnosis and clinical features of disease. Traditional methods of treatment and prevention of disease.
презентация [1,0 M], добавлен 22.09.2014Etiology and pathogenesis, types, treatment of pulpits. Inflammation of dental pulp. An infection (microorganisms) which penetrats in the cavity of pulp chamber. Test of healthy pulp. Tapping of tooth directly. Root canal treatment. Tooth extraction.
презентация [851,9 K], добавлен 31.05.2016Neonatology is a subspecialty of pediatrics that consists of the medical care of newborn infants, especially the ill or premature newborn. The principal patients of neonatologists. Special education physician to become a neonatologist. Functions nurses.
презентация [796,4 K], добавлен 26.05.2014Agranulocytosis - pathologic condition, which is characterized by a greatly decreased number of circulating neutrophils. Epidemiology and pathophysiology of this disease. Hereditary disease due to genetic mutations. Signs and symptoms, treatment.
презентация [1,8 M], добавлен 25.02.2014Pneumonia is an inflammatory condition of the lung—affecting primarily the microscopic air sacs known as alveoli. The bacterium Streptococcus pneumoniae is a common cause of pneumonia. Symptoms, diagnostics, treatment and prevention of this disease.
презентация [279,8 K], добавлен 12.11.2013Principles and types of screening. Medical equipment used in screening. identify The possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms. Facilities for diagnosis and treatment. Common screening programmes.
презентация [921,2 K], добавлен 21.02.2016Description of the directions of medical education in USA. The requirement for continuous training of doctors. Characteristics of the levels of their training to work with patients. Licensing of doctors through specialized advice and terms of the license.
презентация [4,0 M], добавлен 10.11.2015Control the doctors’ prescriptions. Microchip in Blood Pressure Pills Nags Patients Who Skip Meds. Microchip implants linked to cancer in animal. Microchip Implants, Mind Control, and Cybernetics. Some about VeriChip. TI microchip technology in medicine.
курсовая работа [732,8 K], добавлен 12.01.2012Gastroesophageal reflux disease. Factors contributing to its the development. Esophageal symptoms of GERD. Aim of treatment. Change the life style. A basic medical treatment for GERD includes the use of prokinetic drugs with antisecretory agents.
презентация [390,7 K], добавлен 27.03.2016Infectious hepatitis - a widespread acute contagious disease. Botkin’s Disease is a viral disease that destroys the liver and bile ducts. Anatomy of the liver. The value of the liver to the body. Causes and signs of the disease. Treatment and prevention.
презентация [4,0 M], добавлен 24.04.2014Learning about peptic ulcers, a hole in the gut lining of the stomach, duodenum or esophagus. Symptoms of a peptic ulcer. Modified classification of gastroduodenal ulcers. Macroscopic and microscopic appearance. Differential diagnosis and treatment.
презентация [1,2 M], добавлен 22.04.2014The main features of uterine fibroids. The development of a tumor from the "embryonic growth site" and a microscopic nodule without signs of cellular differentiation to a macroscopic nodule. Study of surgical and conservative treatment of leiomyoma.
презентация [1,4 M], добавлен 31.10.2021Risk Factors. The following symptoms may indicate advanced disease. A barium contrast study of the small intestine. Surgical removal is the primary treatment for cancer of the small intestine. The association of small bowel cancer with underlying.
презентация [4,1 M], добавлен 28.04.2014The etiology of bronchitis is an inflammation or swelling of the bronchial tubes (bronchi), the air passages between the nose and the lungs. Signs and symptoms for both acute and chronic bronchitis. Tests and diagnosis, treatment and prevention disease.
презентация [1,8 M], добавлен 18.11.2015Tachycardia is a heart rate that exceeds the normal range. Symptoms and treatment methods of tachycardia. An electrocardiogram (ECG) is used to classify the type of tachycardia. It's important to get a prompt, accurate diagnosis and appropriate care.
презентация [596,2 K], добавлен 20.11.2014
